Our interventional cardiology fellowship program is known for its high volume of STEMI, complex PCI and structural heart disease. Exposure to mechanical circulatory support is frequent and routine. The structural heart program is robust, with high volume commercial interventions such as TAVR and TEER. We also participate in cutting edge trials, most recently Triscend II and Apollo. The environment is collegial and inviting, making it one of the top programs to train in interventional cardiology.